Logo image of ISPO

INSPIRATO INC (ISPO) Stock Fundamental Analysis

NASDAQ:ISPO - Nasdaq - US45791E2063 - Common Stock - Currency: USD

2.97  -0.03 (-1%)

After market: 2.85 -0.12 (-4.04%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ISPO. ISPO was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of ISPO have multiple concerns. ISPO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ISPO has reported negative net income.
In the past year ISPO has reported a negative cash flow from operations.
In the past 5 years ISPO always reported negative net income.
In the past 5 years ISPO always reported negative operating cash flow.
ISPO Yearly Net Income VS EBIT VS OCF VS FCFISPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

ISPO has a worse Return On Assets (-1.86%) than 70.99% of its industry peers.
Industry RankSector Rank
ROA -1.86%
ROE N/A
ROIC N/A
ROA(3y)-7.74%
ROA(5y)-5.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ISPO Yearly ROA, ROE, ROICISPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

ISPO has a worse Gross Margin (31.32%) than 74.05% of its industry peers.
ISPO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ISPO Yearly Profit, Operating, Gross MarginsISPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

ISPO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ISPO has more shares outstanding
ISPO has a worse debt/assets ratio than last year.
ISPO Yearly Shares OutstandingISPO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ISPO Yearly Total Debt VS Total AssetsISPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ISPO has an Altman-Z score of -1.46. This is a bad value and indicates that ISPO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ISPO (-1.46) is worse than 90.84% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.46
ROIC/WACCN/A
WACC8.92%
ISPO Yearly LT Debt VS Equity VS FCFISPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

2.3 Liquidity

A Current Ratio of 0.28 indicates that ISPO may have some problems paying its short term obligations.
ISPO has a worse Current ratio (0.28) than 90.08% of its industry peers.
A Quick Ratio of 0.28 indicates that ISPO may have some problems paying its short term obligations.
The Quick ratio of ISPO (0.28) is worse than 87.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
ISPO Yearly Current Assets VS Current LiabilitesISPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

ISPO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.77%, which is quite impressive.
ISPO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.42%.
EPS 1Y (TTM)86.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.87%
Revenue 1Y (TTM)-16.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.89%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ISPO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.81% yearly.
EPS Next Y57.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.93%
Revenue Next 2Y48.83%
Revenue Next 3Y37.56%
Revenue Next 5Y26.81%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ISPO Yearly Revenue VS EstimatesISPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
ISPO Yearly EPS VS EstimatesISPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ISPO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ISPO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ISPO Price Earnings VS Forward Price EarningsISPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISPO Per share dataISPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ISPO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSPIRATO INC

NASDAQ:ISPO (8/15/2025, 8:00:02 PM)

After market: 2.85 -0.12 (-4.04%)

2.97

-0.03 (-1%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-11 2025-08-11
Earnings (Next)10-27 2025-10-27
Inst Owners4.66%
Inst Owner Change16.37%
Ins Owners4.93%
Ins Owner Change-0.04%
Market Cap36.98M
Analysts43.33
Price TargetN/A
Short Float %1.77%
Short Ratio2.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)107.37%
Min EPS beat(2)76.61%
Max EPS beat(2)138.13%
EPS beat(4)2
Avg EPS beat(4)32.7%
Min EPS beat(4)-51.11%
Max EPS beat(4)138.13%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.39%
Min Revenue beat(2)-5.28%
Max Revenue beat(2)6.05%
Revenue beat(4)2
Avg Revenue beat(4)-1.51%
Min Revenue beat(4)-7.63%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-2.46%
Revenue beat(12)5
Avg Revenue beat(12)-1.34%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.5
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)-1.66
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS21.33
BVpS-10.05
TBVpS-11.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.86%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.32%
FCFM N/A
ROA(3y)-7.74%
ROA(5y)-5.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 47.01%
Cap/Sales 2.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z -1.46
F-Score3
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)143.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.32%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.87%
EPS Next Y57.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-17.89%
Revenue Next Year-10.93%
Revenue Next 2Y48.83%
Revenue Next 3Y37.56%
Revenue Next 5Y26.81%
EBIT growth 1Y32.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year116.21%
EBIT Next 3Y50.9%
EBIT Next 5Y45.76%
FCF growth 1Y69.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.98%
OCF growth 3YN/A
OCF growth 5YN/A